Junior group leader at CCII Kyoto. Cancer immunology scientist. To beat cancer.
Glasgow, UK to Kyoto, Japan
Joined March 2020
- Tweets67
- Following166
- Followers92
- Likes118
僕も登壇します。
学術集会3日目の9/26には、Cancer Research Career Forumの第1回「若手研究者編」を開催します。
テーマは「研究者の仕事と現実、そして未来を語ろう！」をです。経験・迷いを持ち寄りつながりを広げる場です。ぜひご来場を！
#JCA85
I started a new role in Kyoto (though it's already been 6 months). Is the weather much different from Glasgow?
I found this in my post box and I am very motivated by this. Our activities are made possible by your donations. Our group leader Prof Seth Coffelt has been supported by £1 million funding to conduct our reserch, and this is what your donations made possible.
It is actually whole-body disease. Currently, little is understood but we are seeing a great progress in this field, or the view to look by the systemic effect.
Submit your abstract by 13 January for our upcoming virtual conference!
Join us in exploring the systemic consequences of cancer: eacr.org/conference/systemic…
Toshiyasu Suzuki retweeted
Submit your abstract by 13 January for our upcoming virtual conference!
Join us in exploring the systemic consequences of cancer: eacr.org/conference/systemic…
Toshiyasu Suzuki retweeted
THE DEFINITIVE AGING ATLAS in @ScienceMagazine 🤯
A panoramic view of cell population dynamics in mammalian aging
science.org/doi/10.1126/scie…
PanSci, a single-cell transcriptome atlas profiling over 20 million cells from 623 mouse tissues across different life stages, sexes & genotypes
Toshiyasu Suzuki retweeted
Don't miss your chance to contribute to the next edition of the EACR-@AstraZeneca conference, bringing the spotlight on ctDNA! Abstract submissions close in one month on 18 November:
eacr.org/conference/circulat…
Excellent paper about a new face of evolutionary old IL17 from @lynchielydia lab!
Delighted to share our paper on adipose gd T cells making IL-17 every night for homeostasis, coordinating lipid metabolism after eating @Nature Huge effort by
@Akaron0884 & @BrennethS and the team and collaborators to work this out. Aaron's Tweetorial 👇
nature.com/articles/s41586-0…
Toshiyasu Suzuki retweeted
Another scientist whose work initially didn't get the recognition that it deserved - Victor Ambros was denied tenure at Harvard, even after publishing the seminal work that resulted in him receiving the Nobel Prize today!
BREAKING NEWS
The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
Toshiyasu Suzuki retweeted
John Jumper went from getting a PhD to getting a Nobel Prize in just seven years!
BREAKING NEWS
The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Chemistry with one half to David Baker “for computational protein design” and the other half jointly to Demis Hassabis and John M. Jumper “for protein structure prediction.”
Toshiyasu Suzuki retweeted
Scotland has detected no cases of cervical cancer in women born between 1988-1996 who were fully vaccinated against HPV between the ages of 12 and 13.
statnews.com/2024/01/25/hpv-…
Toshiyasu Suzuki retweeted
Registration is OPEN for our brand new conference, Cancer and Ageing, fostering interdisciplinary dialogue among researchers and clinicians.
As always, EACR members benefit from discounted registration rates!
Don't miss it: eacr.org/conference/canceran…
Toshiyasu Suzuki retweeted
Over £1000 raised so far for 2 great charities @PCR_News @ProstateUK. Well done to everyone at @CRUK_SI and @UofGCancerSci for raising awareness of Prostate Cancer.
We organised ECR event: career development in academia supported by @CRUKScotland today! Thank you Welcome trust, Tenovus Scotland, and ERC and UKRI TRI team in University of Glasgow and our superstars in @UofGCancerSci and @CRUK_SI !
Toshiyasu Suzuki retweeted
We are delighted to announce that Professor Edith Heard has been appointed as our new director and chief executive!
Edith, who is currently director-general at @EMBL, will succeed Paul Nurse in leading the Crick from the summer of 2025.
🔗 crick.ac.uk/news/2024-07-09_…
ALT "The Francis Crick Institute has quickly established a global reputation for its work at the frontiers of science. I relish the challenge of building on that work. I also want to pay tribute to Sir Paul Nurse, without whom the Francis Crick Institute would not be the world-leading institution it is today." - Edith Heard
Toshiyasu Suzuki retweeted
Delighted to share the most recent work from our lab where we identify a role for DOCK2-loss mediated immune dysfunction in IBD-associated colorectal cancer. Great work @amd_churchhouse !
nature.com/articles/s41388-0…
